-
Diagnostics World | PerkinElmer has acquired Covaris; Revvity has launched its EONIS Q system, which can help test for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns; Edinburgh Innovations has announced a novel 3D printed device that could replace the need for drug and chemical safety testing on animals; and more.
Dec 28, 2023
-
Diagnostics World | PCORI approves funding awards meant to fill evidence gaps related to multiple different illnesses; Apple Tree Partners will expand its portfolio company Deep Apple Therapeutics to rapidly discover novel small molecule therapeutics for high-value targets through virtual screening of AI-generated virtual libraries; Pepper Bio, the “Google Maps for drug discovery,” plans to accelerate its transomics platform capabilities, fueling the pipeline for more accurate and accessible drug discovery; and more.
Dec 27, 2023
-
Diagnostics World | There is mounting evidence that epigenetics—the molecular processes that influence how genes are expressed—is an equally if not more important driver of disease conditions and phenotypic differences than genetics. That means that accelerating the shift from reactionary medicine to preventive care is going to require biomarkers of these heritable and reversible changes.
Dec 21, 2023
-
Diagnostics World | A decade ago, the National Institutes of Health (NIH) launched a program designed to answer fundamental questions about extracellular RNA (exRNA), such as how it is used by cells and distant organs and if diseased and healthy cells produce different varieties of it. The program concludes at the end of this year but leaves science with technologies to address some of the biggest bottlenecks encountered by researchers in the niche field of study
Dec 19, 2023
-
Diagnostics World | On Sunday, Illumina announced that the company will divest GRAIL.
Dec 17, 2023